PYXS

NASDAQStock

Pyxis Oncology, Inc.

$1.53+0.01 (+0.33%)

52-Week Range

$0.88

$5.34

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.46

Volume

210.3K

Avg Volume

289.2K

Performance

+13.33%

-63.57%

-19.47%

YTD

+33.04%

+37.84%

-23.88%

-88.41%

Price Chart

ETF Exposure

PYXS is held by 12 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.01%	124,643	$194K	$1.27B	0.60%
SBIO.L	Invesco NASDAQ Biotech UCITS ETF	0.01%	0	$0	$416.2M	0.40%
IBB	iShares Biotechnology ETF	0.01%	350,874	$547K	$8.50B	0.44%
IBBQ	Invesco Nasdaq Biotechnology ETF	0.01%	3,526	$6K	$72.1M	0.19%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.01%	2,795	$4K	$86.8M	1.19%
VXF	Vanguard Extended Market ETF	0.00%	537,817	$780K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	70	$137	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,498	$5K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	12	$23	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,422,296	$2.1M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	7,481	$15K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	645	$1K	$1.29B	0.17%

About PYXS ETF Exposure

Pyxis Oncology, Inc. (PYXS) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.53. Investors can gain exposure to PYXS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PYXS, sorted by portfolio weight.